Negative regulation of osteoclast development

pathway activity — cross-omics
GO:2001205Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of osteoclast development pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are FGF7, SFRP2, and SFRP4, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of osteoclast development activity versus FGF7 in BRCA (Pearson r = 0.29).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAFGF7 →+0.985+0.845.001<.00136
OVSFRP2 →+3.160+0.729<.001<.00135
BRCASFRP4 →+1.323+0.701<.001.00135
GBMVENTX →+0.706+0.171.001<.00135
LSCCTMEM97 →-0.790-0.391<.001<.00135
LSCCHSD11B1 →+0.749+0.505<.001.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:2001205 vs FGF7 — BRCA

Per-sample scatter of Negative regulation of osteoclast development activity vs FGF7 in BRCA.

Explore this scatter interactively →

Exploration